Alfuzosin
Also known as: Alfuzosin hydrochloride
Active ingredient description
Alfuzosin is an orally active quinazoline derivative. It is a selective, peripherally acting antagonist of postsynaptic alpha-1-adrenoceptors. In vitro pharmacological studies have documented the selectivity of alfuzosin for the alpha-1-adrenoreceptors located in the prostate, bladder base and prostatic urethra.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Chemical formula: C₁₉H₂₇N₅O₄
Molecular mass: 389.449 g/mol
External identifiers
Medicines
Alfuzosin is an active ingredient of these brands:
United States (US)
- UROXATRAL as ALFUZOSIN HYDROCHLORIDE
Australia (AU)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Austria (AT)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Brazil (BR)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Canada (CA)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Ecuador (EC)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Estonia (EE)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Finland (FI)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Germany (DE)
- UROXATRAL as ALFUZOSIN HYDROCHLORIDE
Hong Kong (HK)
Italy (IT)
Lithuania (LT)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Malta (MT)
Mexico (MX)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Netherlands (NL)
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Nigeria (NG)
- FUZOTRAL as ALFUZOSIN HYDROCHLORIDE
Poland (PL)
Singapore (SG)
- RANFUZOSIN as ALFUZOSIN HYDROCHLORIDE
- XATRAL as ALFUZOSIN HYDROCHLORIDE
Spain (ES)
- BENESTAN as ALFUZOSIN HYDROCHLORIDE
- UNIBENESTAN as ALFUZOSIN HYDROCHLORIDE
Turkey (TR)
United Kingdom (UK)
While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.